Actinium Announces Start of Collaboration to Manufacture IomabTM-B...

Actinium Pharmaceuticals, Inc. , a biopharmaceutical company developing innovative targeted payload immunotherapeutics for the treatment of advanced cancers, announced that it made further steps towards centralized current good manufacturing practice manufacturing of its lead drug candidate Iomab-B.

http://ift.tt/RopQNX